Switch theme
Sign up to access all valuation multiples
Zhejiang Jolly Pharmaceutical Co Ltd is a China-based company engaged in the production and distribution of pharmaceutical products. Its production lines include raw materials, tablets, capsules, particles and frozen dry powder injection. Its products include Wuling powder, Wuling capsule, linglianhua particle, clindamycin phosphate injection and other.
2000
n/a
LTM Revenue $396M
LTM EBITDA $99.4M
$1.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Zhejiang Jolly has a last 12-month revenue (LTM) of $396M and a last 12-month EBITDA of $99.4M.
In the most recent fiscal year, Zhejiang Jolly achieved revenue of $358M and an EBITDA of $94.1M.
Zhejiang Jolly expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Zhejiang Jolly valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $396M | XXX | $358M | XXX | XXX | XXX |
| Gross Profit | $243M | XXX | $218M | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 61% | XXX | XXX | XXX |
| EBITDA | $99.4M | XXX | $94.1M | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 26% | XXX | XXX | XXX |
| EBIT | $94.4M | XXX | $86.3M | XXX | XXX | XXX |
| EBIT Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| Net Profit | $79.8M | XXX | $70.5M | XXX | XXX | XXX |
| Net Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Zhejiang Jolly's stock price is CNY 16 (or $2).
Zhejiang Jolly has current market cap of CNY 11.3B (or $1.6B), and EV of CNY 11.0B (or $1.5B).
See Zhejiang Jolly trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.5B | $1.6B | XXX | XXX | XXX | XXX | $0.11 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Zhejiang Jolly has market cap of $1.6B and EV of $1.5B.
Zhejiang Jolly's trades at 4.3x EV/Revenue multiple, and 16.3x EV/EBITDA.
Equity research analysts estimate Zhejiang Jolly's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Zhejiang Jolly has a P/E ratio of 19.6x.
See valuation multiples for Zhejiang Jolly and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.6B | XXX | $1.6B | XXX | XXX | XXX |
| EV (current) | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| EV/Revenue | 3.9x | XXX | 4.3x | XXX | XXX | XXX |
| EV/EBITDA | 15.4x | XXX | 16.3x | XXX | XXX | XXX |
| EV/EBIT | 16.2x | XXX | 17.8x | XXX | XXX | XXX |
| EV/Gross Profit | 6.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | 19.6x | XXX | 22.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 323.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialZhejiang Jolly's last 12 month revenue growth is 24%
Zhejiang Jolly's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Zhejiang Jolly's rule of 40 is 51% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Zhejiang Jolly's rule of X is 85% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Zhejiang Jolly and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 24% | XXX | 24% | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | 27% | XXX | 26% | XXX | XXX | XXX |
| Rule of 40 | 51% | XXX | 50% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 85% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 29% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 37% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Zhejiang Jolly acquired XXX companies to date.
Last acquisition by Zhejiang Jolly was XXXXXXXX, XXXXX XXXXX XXXXXX . Zhejiang Jolly acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Zhejiang Jolly founded? | Zhejiang Jolly was founded in 2000. |
| Where is Zhejiang Jolly headquartered? | Zhejiang Jolly is headquartered in China. |
| Is Zhejiang Jolly publicy listed? | Yes, Zhejiang Jolly is a public company listed on SHE. |
| What is the stock symbol of Zhejiang Jolly? | Zhejiang Jolly trades under 300181 ticker. |
| When did Zhejiang Jolly go public? | Zhejiang Jolly went public in 2011. |
| Who are competitors of Zhejiang Jolly? | Similar companies to Zhejiang Jolly include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Zhejiang Jolly? | Zhejiang Jolly's current market cap is $1.6B |
| What is the current revenue of Zhejiang Jolly? | Zhejiang Jolly's last 12 months revenue is $396M. |
| What is the current revenue growth of Zhejiang Jolly? | Zhejiang Jolly revenue growth (NTM/LTM) is 24%. |
| What is the current EV/Revenue multiple of Zhejiang Jolly? | Current revenue multiple of Zhejiang Jolly is 3.9x. |
| Is Zhejiang Jolly profitable? | Yes, Zhejiang Jolly is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Zhejiang Jolly? | Zhejiang Jolly's last 12 months EBITDA is $99.4M. |
| What is Zhejiang Jolly's EBITDA margin? | Zhejiang Jolly's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Zhejiang Jolly? | Current EBITDA multiple of Zhejiang Jolly is 15.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
